Expert Comparison: Mechanism, Dosing & Practical Differences
Understanding What Is The Difference Between Wegovy And Mounjaro: Online Prescription Access
The fundamental difference between Wegovy and Mounjaro lies in how they work within your body's hormone systems. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics one natural fullness hormone, whilst Mounjaro contains tirzepatide, a dual-action treatment targeting both GIP and GLP-1 receptors simultaneously. This dual mechanism makes Mounjaro unique in the weight management landscape, potentially offering different appetite control patterns compared to Wegovy's single-pathway approach.
When accessing these treatments online, understanding what is the difference between Wegovy and Mounjaro helps your prescriber recommend the most suitable option during your clinical assessment. Our licensed UK prescribers (GPhC #9012878) evaluate your medical history, current medications, and weight management goals to determine which mechanism aligns with your individual needs. Both treatments require the same clinical assessment process, making it convenient to explore either option through a single online consultation.
Wegovy vs Mounjaro Pricing: What Is The Difference Between Treatment Costs
Wegovy pricing at EverydayMeds starts with the 0.25mg starter dose at £79.99, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to the maintenance dose of 2.4mg at £209.99. New customers apply code FIRST40 at checkout, whilst returning customers use DOSE25 to reach these final prices. Our bundles provide convenience for dose progression, such as the Intro Trio (0.25mg, 0.5mg & 1mg) for £299.99, ensuring seamless treatment continuation without multiple orders.
Mounjaro follows a different pricing structure due to its distinct active ingredient and manufacturing process. When considering what is the difference between Wegovy and Mounjaro costs, both treatments represent significant monthly investments requiring careful budgeting. Your prescriber can discuss cost-effectiveness based on your expected treatment duration and dose requirements. Both treatments are prescription-only medicines requiring ongoing clinical supervision, which is included in our comprehensive online service alongside temperature-controlled delivery and storage guidance.
Clinical Evidence: What Is The Difference Between Wegovy And Mounjaro Trial Results
Wegovy's clinical foundation comes from the STEP trial programme, where patients taking semaglutide alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks in STEP 1, compared to 2.4% with placebo. The SELECT cardiovascular outcomes trial demonstrated a 20% reduction in major cardiovascular events, establishing Wegovy's broader health benefits beyond weight management.
Mounjaro's evidence stems from the SURMOUNT trials, showing different weight loss patterns due to its dual GIP/GLP-1 mechanism. However, comparing what is the difference between Wegovy and Mounjaro trial results directly isn't appropriate, as these studies involved different patient populations, trial designs, and endpoints. Your prescriber evaluates which treatment's clinical profile better matches your medical circumstances and weight management objectives.
How Wegovy Works: GLP-1 Mechanism Explained
Wegovy functions as a GLP-1 receptor agonist, mimicking the natural hormone GLP-1 that your intestines produce after eating. This hormone signals your brain's appetite centres to reduce hunger and increase feelings of fullness after smaller meals, effectively recalibrating your body's satiety responses. The treatment may also slow gastric emptying, helping you feel satisfied for longer periods between meals. Additionally, Wegovy can influence food cravings by affecting reward pathways in the brain associated with eating behaviours. These mechanisms work together to support weight management when combined with a reduced-calorie diet and increased physical activity, as required for all weight management treatments in the UK.
Online Ordering Process: Accessing Both Treatment Options
Our streamlined process begins with a 3-minute clinical assessment covering your medical history, current medications, BMI calculation, and weight management goals. You'll indicate whether you're comparing what is the difference between Wegovy and Mounjaro or have already decided on a specific treatment. Licensed UK prescribers review every assessment within 3 working days (or 24 hours with express service), providing personalised recommendations based on your individual circumstances. Once approved, your prescription-only medicine ships via next-day cold-chain delivery, maintaining the required 2-8°C temperature throughout transit. Our pharmacy team (GPhC #9012878) includes comprehensive injection instructions, storage guidelines, and ongoing support information with every order.
Storage Advantages: What Is The Difference Between Wegovy And Mounjaro Stability
A significant practical difference lies in room temperature storage capabilities once removed from refrigeration. Wegovy can remain stable for up to 6 weeks at room temperature below 30°C, whilst Mounjaro maintains stability for 21 days under similar conditions. This storage advantage makes Wegovy particularly suitable for frequent travellers or those with limited refrigerator space. Both treatments arrive in temperature-controlled packaging and require refrigerated storage (2-8°C) before first use. The FlexTouch pen design used for Wegovy offers intuitive dose selection and injection, with clear dosing windows to track your medication usage. Understanding these practical differences helps determine which treatment better fits your lifestyle and travel requirements.
Personalised Treatment Selection: What Is The Difference Between Wegovy And Mounjaro For Your Needs
Your medical history significantly influences which treatment proves most suitable, as certain conditions may favour one mechanism over another. Patients with specific gastrointestinal sensitivities might respond differently to GLP-1-only versus dual GIP/GLP-1 action, making prescriber guidance essential. Previous experience with diabetes medications, family history of thyroid conditions, and current medication interactions all factor into treatment selection.
The dosing progression also differs between treatments, with Wegovy following a structured 16-week escalation to maintenance dose, whilst Mounjaro uses its own titration schedule. Understanding what is the difference between Wegovy and Mounjaro regarding dose flexibility helps align treatment with your tolerance patterns and lifestyle preferences. Both treatments require long-term commitment for sustained benefits, as weight regain commonly occurs if treatment stops.
Making Your Decision: Wegovy And Mounjaro Both Available Through EverydayMeds
Rather than choosing blindly between these treatments, our clinical assessment process helps identify which option suits your specific circumstances best. Both Wegovy and Mounjaro are available through EverydayMeds, allowing you to access expert guidance about what is the difference between Wegovy and Mounjaro from qualified healthcare professionals. Your prescriber considers factors including your medical history, lifestyle requirements, budget constraints, and treatment preferences when making recommendations. New customers can begin their assessment today using code FIRST40 for optimal pricing, whilst our comprehensive support ensures you understand injection technique, storage requirements, and expected treatment timeline. Visit https://everydaymeds.co.uk/collections/wegovy to start your clinical assessment and receive personalised treatment guidance from our expert team.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
